MODIFIED ADENOVIRAL FIBER ABLATED IN BINDING TO GLYCOSAMINOGLYCAN OR SIALIC ACIDCONTAINING CELLULAR RECEPTORS

Details for Australian Patent Application No. 2003247128 (hide)

Owner TRANSGENE S.A.

Inventors LEGRAND, Valerie; ROSA-CALATRAVA, Manuel; LEISSNER, Philippe

Pub. Number AU-A-2003247128

PCT Number PCT/IB03/03336

PCT Pub. Number WO2004/007537

Priority 02360204.8 10.07.02 EP; 60/409,228 10.09.02 US

Filing date 10 July 2003

Wipo publication date 2 February 2004

International Classifications

C07K 014/07 Peptides having more than 20 amino acids

Event Publications

2 October 2003 Complete Application Filed

  Priority application(s): 02360204.8 10.07.02 EP; 60/409,228 10.09.02 US

18 March 2004 Application Open to Public Inspection

  Published as AU-A-2003247128

11 August 2005 Amendment Made

  The nature of the amendment is: Amend the invention title to read Modified adenoviral fiber with ablated binding to cellular receptors

4 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003247129-SYSTEM, METHOD, DEVICE, AND COMPUTER PROGRAM PRODUCT FOR EXTRACTION, GATHERING, MANIPULATION, AND ANALYSIS OF PEAK DATA FROM AN AUTOMATED SEQUENCER

2003247127-METHOD AND APPARATUS FOR ANALYZING BIOLOGICAL TISSUE IMAGES